Reversible reduction of cardiac sympathetic innervation after coronary artery bypass graft surgery: An observational study using serial iodine 123–labeled meta-iodobenzyl-guanidine (MIBG) imaging  by Katsikis, Athanasios et al.
P
M
Perioperative Management Katsikis et alReversible reduction of cardiac sympathetic innervation after
coronary artery bypass graft surgery: An observational study using
serial iodine 123–labeled meta-iodobenzyl-guanidine (MIBG)
imagingAthanasios Katsikis, MD, George Ekonomopoulos, MD, Spyros Papaioannou, MD, Anna Kouzoumi, and
Maria Koutelou, PhDFrom th
Disclosu
Receive
public
Address
Athen
0022-52
Copyrig
doi:10.1
210Objectives: Various types of surgical and interventional procedures have been reported to cause cardiac
sympathetic denervation. We aimed at evaluating the effects of coronary artery bypass grafting (CABG) in
cardiac sympathetic innervation through meta-iodobenzyl-guanidine (MIBG) imaging.
Methods:MIBG imaging was performed in 21 patients with coronary artery disease (CAD) 1 day before and 1
week and 6 months after CABG with concomitant measurements of corrected QT interval. In each study we
evaluatedMIBG defect score in a 16-segment left ventricular model,MIBG-defect size (percent) from generated
polar maps, and heart/mediastinum ratio.
Results:Mean MIBG defect score and size were increased (32 9.5 vs 24 5, P<.0001, and 49.5% 20.4%
vs 37% 8.7%, P¼ .004, respectively) and mean heart/mediastinum ratio was reduced (1.5 0.4 vs 1.9 0.3,
P<.0001) at 1 week after CABG. At 6 months these indices had no significant differences compared with their
pre-CABG values. Mean corrected QT interval demonstrated no significant changes. Increase in MIBG score in
the second imaging was associated with adverse events related to arrhythmia and myocardial dysfunction during
the 6-month follow-up period in a binary logistic regression model.
Conclusions: CABG is associated with clinically important but reversible reduction in cardiac sympathetic
nerve function, with periprocedural effects (cardioplegia, hypothermia, ischemia, direct nerve injury) being
possible mechanisms for this finding. (J Thorac Cardiovasc Surg 2012;144:210-6)Supplemental material is available online.
The autonomic nervous system plays a major role in the re-
gulation of cardiac function and many cardiac disorders in-
volve alterations of cardiac adrenergic neurotransmission.1
Meta-iodobenzyl-guanidine (MIBG) is an analog of the
adrenergic blocking agent guanethidine and follows the
same active uptake, storage, and release pathways in the
sympathetic nerve endings as does norepinephrine.
MIBG labeling with iodine 123 (123I) allows for imaging;
thus quantitative 123I-MIBG imaging is a direct, noninva-
sive, in vivo method of assessment of global and regional
sympathetic integrity, by measurement of MIBG uptake,2
and function, by measurement of MIBG washout.e Onassis Cardiac Surgery Center, Athens, Greece.
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The Journal of Thoracic and Cardiovascular SurgDiminished MIBG uptake has been related to reduction
in cardiac sympathetic nerve function (CSNF) in the setting
of various heart diseases.3-5 123I-MIBG imaging has
provided important insights to the pathophysiologic
mechanisms of these disorders with good evidence for
prognostic significance in many cases.6,7
There is evidence that reduction in CSNF can also be ob-
served after coronary artery bypass graft (CABG) surgery,
but only limited data about the role of MIBG imaging in
this setting exist.8
The present study examines whether CABG-induced
reduction in CSNF occurs in patients with multivessel cor-
onary artery disease (CAD), to what extent this phenome-
non is reversed after CABG, and whether it has any
effects on postprocedural morbidity and mortality.METHODS
Patients
Twenty-one patients with CAD were prospectively studied. Inclusion
criteria were as follows: multivessel CAD amenable to revascularization
and elective CABG procedure indicated for active angina, more than
low-risk features in noninvasive testing, or 3-vessel disease in association
with proximal left anterior descending artery (LAD) disease, reduced
systolic function, or diabetes. Exclusion criteria were as follows: previous
myocardial infarction (MI) less than 1 month before the operation,ery c July 2012
Abbreviations and Acronyms
CABG ¼ coronary artery bypass graft
CAD ¼ coronary artery disease
CPB ¼ cardiopulmonary bypass
CRRAEs ¼ CSNF reduction-related adverse
events
CSNF ¼ cardiac sympathetic nerve function
H ¼ whole heart
ICU ¼ intensive care unit
123I-MIBG ¼ iodine 123–labeled meta-
iodobenzyl-guanide
LAD ¼ left anterior descending artery
LCx ¼ left circumflex coronary artery
M ¼ upper mediastinum
MI ¼ myocardial infarction
MIBG ¼ meta-iodobenzyl-guanide
QTc ¼ corrected QT interval
RCA ¼ right coronary artery
SPECT ¼ single photon emission computerized
tomography
TDS ¼ total defect score
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Msymptoms of acute coronary syndrome or positive cardiac biomarkers be-
fore CABG, diseases of the central or peripheral nervous system, history of
thyroid disease, and pre-existing renal failure.
According to these criteria, 21 consecutive, eligible patients who under-
went coronary angiography in our institution from January 1 to August 1,
2008, and received a recommendation for surgical revascularization were
enrolled in our study, providing written informed consent, and the study
was approved by the Ethics Committee of the Onassis Cardiac Surgery
Center.
Patients’ characteristics are shown in Table 1. On enrollment, 19 patients
were receiving beta-blockers, 15, oral nitrates, 12, statins, and none was
receiving calcium channel blocker; all of them received aspirin. At 6months,
beta-blocker and aspirin use remained unchanged, whereas statin use had in-
creased (16 patients) and nitrate use had decreased (1 patient). In cases in
which patients were usingmedications known to interferewithMIBGuptake
and biodistribution other than beta-blockers, these drugs were withheld for
2 days before 123I-MIBG imaging. Detailed information about patients’
medications at each stage of the study can be found in Table E1.
Seven patients had a history of type II diabetes for a mean duration of
12.1  3.2 years. Ten patients had a history of at least 1 MI, dating 4 to
228 months (median duration, 9 months) before CABG. All of these
patients had at least 1 previous ST-segment elevation MI (4 infarcts in
the LAD, 6 in the right [RCA], and 1 in the left circumflex [LCx]
coronary artery distribution) and 3 of them also had a history of non–
ST–segment elevation MI, while in total there were 3 patients with mul-
tiple MIs.
Study Protocol
123I-MIBG scintigraphy was performed 1 day before and both 1 week
and 6 months after cardiac surgery. At the same time points electrocardio-
grams were taken for determination of corrected QT interval (QTc).
Furthermore, blood samples were drawn for determination of complete
blood count, common biochemistry panel, and myocardial enzymes during
the first 7 days of the postoperative period as a standard follow-up
procedure for patients undergoing CABG.The Journal of Thoracic and CaThe second 123I-MIBG imaging took place after patients had been trans-
ported from the intensive care unit (ICU) to common hospital wards.
Aortic crossclamp time and total time of extracorporeal circulation
were recorded for each patient, and postprocedural serial measurement
of myocardial enzyme activity was used according to standard ICU
policy for the treatment of patients after CABG. Elevations of creatine
kinase MB and/or cardiac troponin I more than 5 times the 99th per-
centile of the normal reference range of our hospital laboratory during
the first 72 hours after CABG were defined as periprocedural myocar-
dial necrosis. When these elevations were combined with new patho-
logic Q waves, left bundle branch block, or the need for repeat
revascularization in the following 7 days, a CABG-related MI was es-
tablished. The definitions used were in accordance with the 2007 con-
sensus document of ESC/ACCF/AHA/WHF regarding the universal
definition of MI.9
Among the various modalities established for the assessment of auto-
nomic nervous system function, we used the QTc interval10 for evaluation
of the effects of sympathetic tone in MIBG scintigraphy findings. QTc is
a reproducible, easily measurable parameter, with the advantage of not re-
quiring patient cooperation.11
Finally, CSNF reduction-related adverse events (CRRAEs)were recorded
per patient to evaluate the possible clinical significance of the observed
changes inCSNF. Such eventswere considered (1) sustained supraventricular
or ventricular arrhythmias documented between the time of postprocedural
restoration of circulation and the third MIBG imaging study and (2) the
need for combined pharmacologic or mechanical support because of low
cardiac output syndrome during the patient’s hospitalization.123I-MIBG Imaging
All subjects received 5 mL of 1% Lugol solution 48 hours before and
48 hours after administration of 123I-MIBG to block tracer uptake in the
thyroid gland.
We performed delayed 123I-MIBG imaging using a single-head, rotating
gamma camera equipped with a low-energy, general-purpose collimator
(ORBITER 75 ZLC; Siemens AG, Munich, Germany).
In the fasting state 5 mCi (185 MBq) of 123I-MIBG (GE Healthcare,
Cygne, Netherlands) was injected intravenously through an antecubital
vein at rest and imaging was started 4 hours after injection for both planar
and single photon emission computerized tomography (SPECT) images.
Anterior (front) planar images of the chest were initially acquired over 5
minutes in a 643 64 matrix. Immediately after planar imaging, 32 images
were obtained in a 64 3 64 matrix for 40 seconds, with a 180 rotation
ranging from the 45 right anterior oblique position to the left posterior
oblique position. Energy discrimination was provided by a 20% window
centered at 159 keV.
On the anterior planar 123I-MIBG images, regions of interest (ROIs)
were drawn manually over the whole heart (H) and upper mediastinum
(M). Using the counts in the regions of interest, the H/M ratio of MIBG
were calculated as follows: H/M¼mean pixel counts of heart region of in-
terest/mean pixel counts of mediastinal region of interest. In our laboratory,
the normal 123I-MIBG H/M ratio values of the delayed images obtained
from age-matched controls are 1.8 to 2.7. Normal subjects consisted of 9
(5 men and 4 women; mean age, 59  9 years) individuals with normal
findings in the echocardiogram and low likelihood of CAD based on risk
factors, history, and electrocardiogram.
After preprocessing with a Butterworth filter (cutoff frequency, 0.44
cycle/cm; power factor, 8), transaxial SPECT images were reconstructed
by filtered back projection without attenuation or scatter correction and
were displayed as short- and long-axis (horizontal and vertical) slices.
Regional uptake was estimated through visual interpretation of SPECT
images performed by 2 experienced observers, using a 16-segment left
ventricular model and a 5-point scoring system (0¼ normal, 1¼ equivocal,
2 ¼ moderate, 3 ¼ severe, 4 ¼ absent). The disagreement in defect score
was resolved by consensus. Segments with a defect score of 2 or morerdiovascular Surgery c Volume 144, Number 1 211
TABLE 1. Patient characteristics
Parameter Value
Gender
Male 19
Female 2
Age (y) 63  8 (55-72)
History of MI 10
Diabetes 7
No. of vessels diseased
3 15
2 6
LVEF (%) 49  6 (35-55)
Anatomic distribution of CAD
No. of patients/degree
of stenosis*
Left main 6/21 (60%-90%)
LAD 21/21 (60%-100%)
Diagonals 7/21 (50%-95%)
LCx 15/21 (60%-100%)
Obtuse marginals 10/21 (60%-100%)
RCA 19/21 (50%-100%)
PDA 6/21 (50%-90%)
Chronic total occlusions No. of patients
Any vessel 10/21
LAD 5/21
LCx/OMs 4/21
RCA 6/21
MI, Myocardial infarction; CAD, coronary artery disease; LAD, left anterior descend-
ing coronary artery; LCx, left circumflex coronary artery; RCA, right coronary artery;
PDA, posterior descending artery (arising from right coronary artery in all patients);
OM, obtuse marginal branches; LVEF, left ventricular ejection fraction. *Number of
patients with disease presence in the reference vessel (defined as stenosis 50% of
the lumen diameter) and range of stenosis percentage (inside parentheses).
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Mwere defined as abnormal and the total MIBG defect score (TDS) was
derived as the sum of all segments.
Furthermore, polar maps were derived from the short-axis SPECT
images using dedicated computer software and were compared with those
of age-matched normal subjects on a pixel-by-pixel basis. Regions of
reduced tracer uptake were defined using a threshold of 50% of the
maximum and defect sizes were measured for the whole left ventricle as
a percentage of the size of the whole myocardium, which was measured
as the volume of the consecutive short-axis slices from base to apex. Re-
gional defect size was also calculated for the 3 regions corresponding to
the 3 coronary arteries.
Statistical Analysis
Analyses were performed with SPSS version 16 software (SPSS, Inc,
Chicago, Ill). All data were expressed as mean values  standard devia-
tion, with selected range values. Repeated-measurements analysis of
variance with the Bonferroni adjustment was performed to compare
TDS, H/M ratio, total and regional defect size, and QTc values between
pre-CABG (condition A), 1 week after CABG (condition B), and 6
months after CABG (condition C) conditions. The Maulchy test of sphe-
ricity was used to test the hypothesis that the variances of differences of
the parameters evaluated were equal among the 3 conditions. When the
Maulchy test statistic was less than .05, the degrees of freedom in the
univariate testing of the effect of serial imaging in the change of the indi-
vidual parameters evaluated were corrected with the Greenhouse-Geisser
correction. Linear regression analysis was used to evaluate the212 The Journal of Thoracic and Cardiovascular Surgrelationship between MIBG uptake and H/M ratio values in the early
and late post-CABG imaging with maximum postprocedural myocardial
enzyme levels and aortic crossclamp times. Binary logistic regression
analysis was used for evaluation of (1) relationships between CRRAEs
and MIBG imaging parameters and (2) variables related to lack of im-
provement in the MIBG defect size/score in the final imaging study com-
pared with baseline. Goodness-of-fit for the latter analysis was examined
using the Hosmer-Lemeshow test.RESULTS
All patients underwent successful coronary artery revas-
cularization, with uncomplicated weaning from cardiopul-
monary bypass (CPB), except for 1 case of successful
open chest cardiac defibrillation for ventricular fibrillation
occurring immediately after restoration of circulation. The
recovery of this patient after that event was unremarkable.
Seven patients received 4 grafts, eight 3 grafts and six 2
grafts. Complete revascularization was achieved in 13 pa-
tients. The mean duration of CPB was 115  33 minutes
(range, 65-189 minutes) and the mean aortic crossclamp
time was 64  30 minutes (range, 31-124 minutes). On
completion of the procedure, patients were transferred ini-
tially to the ICU, where they remained for a median dura-
tion of 2 days on temporary low-dose combined inotropic
support (dobutamine and dopamine), according to standard
ICU policy. Inotrope administration was terminated on ICU
discharge. During ICU stay, 2 patients required a short
period of intensive circulatory support to reverse fluid
challenge–resistant hypotension associated with oliguria
(<0.5 mL $ kg1 $ h1). One patient required a purely phar-
macologic treatment (vassopressors and high dobutamine
dose) and the other a combination of pharmacologic and
intra-aortic balloon counterpulsation support.
Temporal elevation of myocardial enzymes indicative of
periproceduralmyocardial necrosiswas observed in 4 patients,
but none of them fulfilled criteria for CABG-related MI.
Enzyme elevation started on the first postoperative day in every
case and lasted for a median duration of 84 hours for creatine
kinase MB, with median maximum values for troponin I and
creatine kinase MB being 39  31 mg/L and 60  59 U/L,
respectively. Two patients had atrial fibrillation on the second
postoperative day, which was successfully terminated with in-
travenous use of amiodarone. These patients were excluded
from analysis of QTc and heart rate statistics. All patients
were discharged home after a mean duration of 9  2 days.
Biochemical parameters with possible implications in the
MIBG imaging results on the day of the second MIBG im-
aging sequence were as follows: hemoglobin, 110 20 g/L;
white blood cell count, 8.7  2.3 $ 109/L; potassium, 4.6 
0.4 mmol/L; and glucose, 7.7  2 mmol/L.
The Maulchy test statistic was less than .05 for total de-
fect size and score and regional defect size for the RCA and
LCx territories (where the Greenhouse-Geisser correction
was used) and nonsignificant for QTc, H/M ratio, and re-
gional defect size for the LAD territory. In univariateery c July 2012
TABLE 2. MIBG scanning parameters of global assessment
Parameter Pre (A)
One week
after (B)
Six months
after (C) P value Mean difference
95% CI for difference
Upper bound Lower bound
H/M ratio 1.9  0.3 1.5  0.4 1.9  0.2 A vs B:<.0001
A vs C: NS
B vs C:<.0001
A-B: .39  .07
A-C: .02  .05
B-C:.37  .06
.21
.12
.54
.57
.17
.19
Total defect score 24  5 32  9.5 23  6 A vs B:<.0001
A vs C: NS
B vs C:<.0001
A-B:8.0  1.54
A-C: .57  .7
B-C: 8.6  1.1
12.0
1.25
5.67
4.0
2.4
11.5
Total defect size (%) 37  8.7 49.5  20.4 36.3  12.6 A vs B: .004
A vs C: NS
B vs C:<.0001
A-B:12.5  3.3
A-C: .6  1.8
B-C: 13.1  2.6
21.3
4.2
6.2
3.8
5.4
20.1
The mean differences are significant at the .05 level, whereas the P values and the confidence intervals are adjusted for multiple comparisons with the Bonferroni correction.
MIBG imaging parameters of global evaluation were measured before and after coronary artery bypass grafting (designated A, B, and C). MIBG, Meta-iodobenzyl-guanide;
CI, confidence interval; H/M, heart/mediastinum; NS, not significant, that is, larger than .05.
Katsikis et al Perioperative Managementtesting, serial imaging had significant interaction with every
parameter evaluated, except for the regional defect size in
the RCA territory.
At 1 week after CABG, patients had a significantly higher
TDS and total defect size and a significantly decreased H/M
ratio compared with the pre-CABG corresponding values.
MIBG uptake was reduced in all but 4 patients.
Six months after surgery, the values of the aforemen-
tioned indices were not significantly different from the
pre-CABG values. MIBG uptake at 6 months, though,
was increased in only 9 patients with regard to the pre-
CABG imaging. Hence, an almost homogeneous and
significant worsening of all MIBG parameters was observed
initially after CABG, with an equally homogeneous im-
provement in these values in the delayed vs the early
post-CABG scans. However, the 6-month post-CABG im-
provement was very variable with respect to the baselineFIGURE 1. Graphic representation of the serial changes in total defect size (le
meta-iodobenzyl-guanide imaging for each of the patients studied. CABG, Cor
The Journal of Thoracic and Castatus, leading to nonsignificant differences of the MIBG
imaging parameters between A and C conditions. The latter
is reflected in the wide 95% confidence intervals of the
mean difference in TDS and size between conditions A
and C, in contrast to the narrow intervals observed in the
comparisons between A and B and B and C. MIBG imaging
parameters of global evaluation (H/M ratio, TDS, and total
defect size) before and after CABG are presented in Table 2,
whereas Figure 1 is a graphic representation of the temporal
trends observed in total defect size and H/M ratio during se-
quential MIBG imaging for each of the patients studied.
In terms of regional evaluation, the temporal pattern of
early decrease and late increase in CSNF was observed in
all pairwise comparisons between the 3 territories studied.
All these changes were statistically significant with the
exception of change from A to B condition for RCA. At 6
months no differences in MIBG size were documentedft panel) and heart/mediastinum (H/M) ratio (right panel) during sequential
onary artery bypass grafting.
rdiovascular Surgery c Volume 144, Number 1 213
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TABLE 3. Local assessment of percent defect size according to the polar maps (bull’s eye) by vessel territory
Vessel territory Before (A)
One week
after (B)
Six months
after (C) P value Mean difference
95% CI for difference*
Upper bound Lower bound
LAD 36.1  10.6 48.1  18.8 30.2  8.5 A vs B: .012
B vs C:<.001
A vs C: NS
A-B:11.96  3.68
B-C: 17.87  3.29
A-C: 5.91  2.88
21.58
9.27
1.61
2.34
26.47
13.43
RCA 44.5  23.1 48.0  26.3 40.5  24.1 A vs B: NS
B vs C: .001
A vs C: NS
A-B:3.51  5.48
B-C: 7.505  1.7
A-C: 4  4.98
17.85
3.05
9.01
10.82
11.96
17.0
LCx 25.6  24.1 61.8  27.9 39.5  17.0 A vs B:<.001
B vs C:<.001
A vs C: .050
A-B:36.2  5.33
B-C: 22.32  3.13
A-C:13.86  5.31
50.1
14.14
27.74
22.26
30.5
0.02
CI, Confidence intervals; LAD, left anterior descending coronary artery; RCA, right coronary artery; LCx, left circumflex coronary artery; NS, not significant, that is, larger than
.05. *The mean differences are significant at the .05 level, and the P values and the confidence intervals are adjusted for multiple comparisons with the Bonferroni correction.
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Table 3 demonstrates the local assessment of percent defect
size by coronary artery territory, according to the polar maps.
QTc values before CABG (422  41 ms) had no statisti-
cally significant differences with the values recorded either
at 1 week (420 33 ms) or at 6 months (424 36 ms) after
CABG.
In linear regression analysis, no correlation was found be-
tween TDS and total defect size or H/M ratio at either 1 week
or 6months after CABG,with aortic crossclamp time ormax-
imum postprocedural myocardial enzyme levels.
At the end of the study, 1 hospitalization but no fatal
events were observed. Hospitalization resulted from an
acute coronary syndrome at 5 months after CABG; the cul-
prit vessel was the posterolateral ventricular branch of theFIGURE 2. Polar maps of 2 representative patients, depicting meta-iodobenzy
(CABG). Tracer uptake before (left column), 1 week after (middle column), and
a 54-year-old woman with 2-vessel coronary artery disease (CAD) who receiv
surgery is clearly demonstrated. Patient B (bottom) is a 67-year-old man with
and 2 venous grafts. Note the significant reduction of MIBG uptake immediat
levels even higher than the ones before surgery. A, Apex; LAD, left anterior de
coronary artery.
214 The Journal of Thoracic and Cardiovascular SurgRCA, which was not revascularized owing to technical dif-
ficulties. In addition, 2 more patients were discovered with
asymptomatic atrial fibrillation at scheduled post-CABG
office visits and underwent successful electric cardiover-
sion after appropriate anticoagulation as day cases at the
hospital. All patients were in sinus rhythm at the end of
the study and a total number of 7 CRRAEs were recorded
during the study’s follow-up. Further follow-up data were
available for a median duration of 590 days after the end
of the study. No late deaths, sustained arrhythmias, or ma-
jor adverse cardiac events were observed during this
period.
MIBG imaging parameters, performance of complete re-
vascularization, prior MI, periprocedural myocardial necro-
sis, age, diabetes, left ventricular ejection fraction, and CPBl-guanide (MIBG) uptake before and after coronary artery bypass grafting
6 months after (right column) CABG surgery is shown. Patient A (top) is
ed 2 venous grafts. Reversible reduction of MIBG uptake at 1 week after
3-vessel CAD who underwent successful CABG surgery with 1 arterial
ely after surgery and the improvement of MIBG uptake 6 months later, at
scending coronary artery; LCx, left circumflex coronary artery; RCA, right
ery c July 2012
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regression analysis with CRRAEs as the dependent vari-
able. Among them, only the difference in MIBG total score
between the first and the second imaging was significantly
related to CRRAEs (P ¼ .028; hazard ratio, 1.155; 95%
confidence intervals for hazard ratio, 1.016-1.314). Using
the same type of analysis and the same variables including
occurrence of postprocedural acute coronary syndrome, no
variables were found to be associated with lack of improve-
ment in MIBG score or size in the last imaging.
Figure 2 depicts the MIBG uptake in 2 representative pa-
tients before surgery and 1 week and 6 months after surgery.
DISCUSSION
Despite the broad spectrum of surgical-interventional
procedures associated with reversible or fixed reduction in
CSNF and abnormal MIBG uptake,12-15 insufficient data
exist to support these phenomena after CABG.8 On the
other hand, Momose and associates16 did not demonstrate
CABG-induced reduction in H/M ratio in a very small series
of patients undergoing MIBG imaging before and late after
the procedure. These 7 patients served as a control group for
the evaluation of CSNF changes after surgical repair of
ascending aortic aneurysm. To our knowledge, this is the
first study to demonstrate that CABG surgery is related to
significant and reversible reduction in CSNF, which is
clinically important.
Concern about possible confounding effects of using
beta-blockers or the presence of patients with diabetes in
the population studied is not justified. The conventional
beta-blockers used have limited effects in MIBG uptake
and biodistribution,17 whereas the comparative nature of
the study under the same treatment environment attenuates
any effect that beta-blockers would have on an isolated
MIBG imaging study. Furthermore, cardiac autonomic
dysfunction in patients with longstanding diabetes is perma-
nent.18 Hence, neither special analysis would be justified,
nor would different results be expected for the diabetic
patients of our study.
There are 2 possible mechanisms responsible for the
reduction of cardiac MIBG uptake: (1) peripheral sympa-
thetic nerve hyperactivity and (2) direct or indirect car-
diac sympathetic nerve damage caused by the CABG
procedure.
Regarding the first mechanism, reduced MIBG uptake
may be seen with high circulating catecholamine levels as
a result of competition for the type 1 uptake mechanism.17
Consequently, a state of peripheral adrenergic hyperactiv-
ity, related to the physical and emotional postoperative
stress, could account for a decreased cardiac MIBG uptake
early after the CABG procedure. Still, in a generalized state
of increased sympathetic tone serious enough to cause com-
petition of peripheral adrenergic nerve endings for MIBG
uptake, QTc should have also been influenced.The Journal of Thoracic and CaWith respect to the other 2 possible mechanisms, the fol-
lowing facts should be noted. All the revascularization proce-
dures using vein grafts had the potential for direct injury to the
cardiac sympathetic nerve plexus that courses along the base
of the great arteries, by adventitia abrasion or by punching out
the wall in the ascending aorta, during proximal graft anasto-
mosis. Furthermore, indirect damage to adrenergic nerve
endings from the neurotoxic effects of periprocedural ische-
mia (iatrogenic or induced by circulatory arrest), cardioplegic
solutions,19,20 and hypothermia21,22 could play amajor role to
the findings of this study.
Early after CABG the combined effect of the above
neurotoxic factors was predominant, leading to significant
deterioration of MIBG imaging parameters despite the
revascularization-induced improvement in blood supply.
As the power of this effect progressively diminished with
time, restoration of MIBG imaging parameters was ob-
served but not improvement compared with their baseline
values. Possibly part of this negative effect is still active
enough to counterbalance the beneficial effect of revascu-
larization even late after CABG. This lack of improvement
supports analogous findings by Hayashi and colleagues8
and deserves special mention. We failed to identify
a specific variable significantly related to this paradox,
a fact that we believe supports the multifactorial cause of
this phenomenon and begs for further study.
Although no concurrent perfusion studies were per-
formed and complete revascularization was not uniformly
achieved, there can be no argument that significant im-
provement in blood supply was achieved and that revascu-
larization was practically the only beneficial intervention
for CSNF between the first and the last MIBG imaging.
Improved medical therapy after surgery, limited to in-
creased postprocedural statin use, had no impact in the
apparent reinnervation inasmuch as statins have never
been documented to affect CSNF.
Finally and most important, the observed sympathetic de-
nervation was found to be clinically relevant. Alterations in
CSNF are implicated in arrhythmogenesis and myocardial
dysfunction, and we demonstrated that the CABG-induced
reduction in CSNF is related to major contributors in post-
procedural morbidity and mortality, namely, arrhythmias23
and operation-induced myocardial stunning.24
Limitations
There are a number of limitations in our study.
First, we did not perform simultaneous myocardial per-
fusion imaging along with MIBG imaging, which could
help in clarifying the cause of our findings, as well as
the exact mechanism for the lack of uniform improve-
ment in postprocedural MIBG uptake compared with
baseline status. Evidence exists, though, for a discrepancy
between MIBG and 201Tl SPECT imaging findings in the
early postoperative period, after successful surgicalrdiovascular Surgery c Volume 144, Number 1 215
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probably attenuated.
Second, we did not use a more direct means of sympa-
thetic tone assessment. Blood catecholamines could be
measured instead of QTc, with its inherent limitations as
a method of evaluating autonomic nervous system status,
but plasma levels of norepinephrine in heart diseases rarely,
if ever, exceed levels that can inhibit MIBG uptake.25
In addition, we used only delayed images for MIBG,
while in patients with previous MI we did not compare
MIBG findings between infarcted and noninfarcted regions.
Finally, this study was not properly controlled, although
it is highly unlikely for either normal persons or subjects
with CAD to have significant, spontaneous changes in
MIBG imaging parameters with time.
We thank Mrs Anna Koutsimpani for her help in preparing the
manuscript.
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TABLE E1. Patients’ medications during MIBG imaging, with the
relative number of patients by medication used
Time point drugs
Before
CABG (A)
One week
after CABG (B)
Six months
after CABG (C)
Beta-blockers 19 19 19
Aspirin 21 21 21
Statin 12 12 16
Nitrates 15 3 1
PPIs 10 17 15
KCl supplements 5 11 4
Analgesics 0 18 0
Metformin 5 5 5
Sulfonylureas 4 4 4
Others* 6 7 5
MIBG, Meta-iodobenzyl-guanide;CABG, coronary artery bypass grafting; PPIs, pro-
ton pump inhibitors. *Non-QT prolonging (according to: www.qtdrugs.org) or MIBG
uptake-affecting drugs (according to Solanki KK, Bomanji J, Moyes J, Mather SJ,
Trainer PJ, Britton KE. A pharmacological guide to medicines which interfere with
the biodistribution of radiolabeled meta-iodobenzylguanidine (MIBG). Nucl Med
Commun. 1992;13:513-21).
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